Form 4: Kenvue Inc. Chief Scientific Officer Reports Stock Transactions
SEC Form 4 Filing
Caroline Tillett, Chief Scientific Officer of Kenvue Inc., reported the vesting of restricted stock units and subsequent tax withholding of shares on December 1, 2024.
Summary
- Caroline Tillett, the Chief Scientific Officer of Kenvue Inc., reported a transaction involving restricted stock units (RSUs) on December 1, 2024.
- 1,498.2 RSUs vested and converted into common stock on a one-for-one basis.
- 767 shares were withheld to cover taxes at a price of $24.08 per share.
- Following these transactions, Ms. Tillett directly owns 21,490.2 shares of Kenvue Inc. common stock.
- The RSUs vest in three equal installments on December 1, 2024, December 1, 2025, and December 1, 2026, contingent on continued service.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation, which is generally neutral to positive. The vesting of RSUs is a positive incentive for the executive.
Positives
- The vesting of restricted stock units indicates a form of compensation and alignment of interests with the company's performance.
- The continued vesting schedule provides an incentive for the officer to remain with the company.
Future Outlook
The remaining restricted stock units will vest in two equal installments on December 1, 2025 and December 1, 2026, subject to the reporting person's continued service.
Industry Context
This is a standard SEC Form 4 filing, which is common for publicly traded companies when executives have transactions involving company stock. It is a routine disclosure and does not indicate any unusual activity.
Comparison to Industry Standards
- The vesting of restricted stock units is a common practice for executive compensation in publicly traded companies, including those in the consumer health sector like Kenvue.
- Similar companies such as Haleon and Procter & Gamble also use equity-based compensation for their executives.
- The tax withholding of shares upon vesting is a standard procedure to cover the tax obligations of the executive.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a small number of shares relative to the total outstanding shares.
- The vesting of RSUs aligns the executive's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 12/01/2024 | Date of the reported stock transaction, including vesting of RSUs and tax withholding. |
| 12/01/2025 | Date of the second vesting installment of the RSUs. |
| 12/01/2026 | Date of the third and final vesting installment of the RSUs. |
| 12/03/2024 | Date the Form 4 was signed. |
Keywords
Kenvue Inc., stock transaction, restricted stock units, RSU, insider trading, Form 4, executive compensation, vesting, share ownership, Chief Scientific Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.